SEC Form D · filed May 14, 2019
INNOVATE BIOPHARMACEUTICALS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Lorin K. Johnson · Raleigh, NCDirectorJay P. Madan · Raleigh, NCExec · DirectorSandeep Laumas · Raleigh, NCExec · DirectorAnthony Maida · Raleigh, NCDirectorSaira K. Ramasastry · Raleigh, NCDirectorRoy K. Proujansky · Raleigh, NCDirectorJeffrey Myers · New York, NYDirectorRyan Belanger-Saleh · New York, NYDirectorJohn Bykowski · Hayward, CAExec · DirectorScott Zeilinger · New York, NYExec · DirectorRuan Van Vuuren · Grand Cayman, Cayman IslandsDirectorArnar Agnarsson · Bozeman, MTDirectorKevin Cavenaugh · Portland, ORExec · DirectorLorne Thomas · Odessa, FLExec · DirectorWilliam P. Corry · Sewickley, PADirectorChristopher Long · Mission Woods, KSDirectorShinji Kim · SAN FRANCISCO, CADirectorCampbell Congdon · Grand Cayman, Cayman IslandsDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗